Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome

Clinical trial NCT05432466 · RECRUITING

Trial details

NCT number: NCT05432466
Sponsor: Acer Therapeutics Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Vascular Ehlers-Danlos Syndrome

Start date: 2022-11-07
Primary completion: 2029-03-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.